Meng Gao

Managing Director – Pivotal Life Sciences, and Managing Partner – Pivotal bioVenture Partners (US & China)
Hong Kong
Focus Area
Venture Capital
Get in Touch

Meng Gao is the Chief Investment Officer of Nan Fung Group. He is responsible for overseeing Nan Fung’s overall investment activities, as well as developing the group’s strategic initiatives including Pivotal Life Sciences. Mr. Gao joined Nan Fung Group in 2015. Prior to joining Nan Fung Group, Mr. Gao was a Managing Director at Blackstone’s Private Equity Group in Hong Kong, where he was involved in a number of transactions across multiple industries. Before joining Blackstone, Mr. Gao was a Senior Vice President at Oaktree Capital Management, where he was involved in sourcing, structuring and executing private equity investments in China. Prior to that, Mr. Gao was an investment banker with Credit Suisse and J.P. Morgan in New York. Mr. Gao received a Bachelor of Economics degree from Peking University, an M.A. from Yale University and an M.B.A. from the Wharton School of the University of Pennsylvania, where he graduated with Honors. Mr. Gao is currently a board member of New Frontier Group and Artic Vision.